Archive for May 2023
A year after acquisition, Entasis’ new antibiotic nets FDA approval
A rarity in the ever-struggling field of novel antibiotics: The FDA has approved a new drug. Read More
Read More‘CMS, fix this mess’: Alzheimer’s advocates rally for drug access in Boston
Several dozen Alzheimer’s disease patients and activists rallied outside the Boston office of the U.S. Center for Medicare and Medicaid Services on Wednesday, calling on the organization to extend coverage for new Alzheimer’s treatments. Read More
Read MoreFirst Citizens lays off hundreds of Silicon Valley Bank workers
The mass layoffs come as the Raleigh bank works to right-size its scope and scale to remain competitive. Read More
Read MoreIs Massachusetts ready for the clean energy transition? Industry leaders weigh in at BBJ event.
With federal incentives on the table, opportunity is ripe to accelerate the clean energy transition. But it’s going to take money and intersectional planning. Read More
Read MoreBizSpotlight: Fuseideas
Boston-based marketing agency Fuseideas is proud t Read More
Read MoreGopuff sues Alcoholic Beverages Control Commission over revoked licenses
The company warned that unless it can quickly resume alcohol delivery services, it could be forced to close all its Massachusetts retail locations due to insufficient sales. Read More
Read MoreTarget pulls some LGBT Pride Month merchandise after threats, backlash
Target Corp. is pulling some of its Pride Month merchandise from stores just weeks after launch, after the displays were targeted by some consumers irate over the Minneapolis-based retailer’s LGBT-themed products. Read More
Read MoreIn another mega-round, ElevateBio raises $401M for cell and gene therapy
The king of mega-rounds has returned. ElevateBio, the cell and gene therapy startup founded by former executives from Alexion Pharmaceuticals and bluebird bio, has raised $401 million in a Series D, two years after it raised a $525 million Series C round. Read More
Read MoreAnalog Devices shares tumble after revenue drop warning
Analog Devices CEO Vincent Roche warned analysts that "continued economic uncertainty" and "normalizing supply chains" are expected to impact revenue in the second half of 2023. Read More
Read MoreSteward Morton Hospital to close substance-use treatment program in Taunton
Just eighteen months after opening a substance abuse recovery program, Steward Morton Hospital in Taunton plans to close the facility against strong opposition from the nursing union, which says the program is essential to the community. Read More
Read More